09:47 AM EST - Crescita Therapeutics Inc. : Announced its financial and operational results for the third quarter ended September 30, 2017. The company reduced Q3-17 operating loss to $1.5 million from $2.9 million in the same quarter of the prior year, and ended the quarter with $8.8 million of cash. Crescita Therapeutics Inc.
shares T.CTX are trading unchanged at $0.74.
